coronavirus Archives - Page 2 of 2 - Knowledge Ecology International

FDA gives Gilead a seven year regulatory monopoly for remdesivir to treat COVID-19, on grounds it is an “Orphan” treating a rare disease

Posted on March 23, 2020 by James Love

Today the FDA granted Gilead Orphan Drug status for remdesivir for the treatment of COVID-19, on grounds this is a rare disease. The morning of the designation, the U.S. had confirmed, through testing, more than 35 thousand cases, including 8,477… Continue Reading →

KEI Letter to Speaker Pelosi Regarding Use of “Other Transaction Authority” (OTA) in Coronavirus Bill to Escape Bayh-Dole Public Interest Safeguards

Posted on March 23, 2020 by KEI Staff

For more on KEI’s work on COVID-19, see keionline.org/coronavirus. On March 23, 2020, Knowledge Ecology International (KEI) sent a letter to Speaker Nancy Pelosi regarding a provision in the current draft of the Senate version of the coronavirus funding bill… Continue Reading →

Patent Troll Files Lawsuit to Block Possible Coronavirus Diagnostic

Posted on March 16, 2020 by Kathryn Ardizzone

For more on KEI’s work on COVID-19, see keonline.org/coronavirus. Global health emergencies such as the COVID-19 pandemic call upon us to answer to the better angels of our nature. Not all are heeding that call. Instead of cooperation and selflessness,… Continue Reading →

Three areas in Section 202 of the Bayh-Dole Act that require action to ensure sufficient rights in patents on coronavirus relevant inventions

Posted on March 14, 2020 by James Love

For more on KEI’s work on COVID-19, see keonline.org/coronavirus. As the US and other governments begin to expend large amounts of money on research and development related to the control, prevention and treatment of the coronavirus pandemic, there are important… Continue Reading →

Categories